Consensus M2e Peptide Conjugated to Gold Nanoparticles Confers Protection Against H1N1, H3N2 and H5N1 Influenza a Viruses

Antiviral Research - Netherlands
doi 10.1016/j.antiviral.2017.01.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

An H5N1 M2e-Based Multiple Antigenic Peptide Vaccine Confers Heterosubtypic Protection From Lethal Infection With Pandemic 2009 H1N1 Virus

Virology Journal
VirologyInfectious Diseases
2010English

Influenza Virus-Like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With a/Pr8 (H1N1) and a/Hk (H3N2) Viruses

Iranian Red Crescent Medical Journal
Medicine
2013English

Reassortment Between Avian H5N1 and Human H3N2 Influenza Viruses Creates Hybrid Viruses With Substantial Virulence

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Reassortment Process After Co-Infection of Pigs With Avian H1N1 and Swine H3N2 Influenza Viruses

BMC Veterinary Research
MedicineVeterinary
2017English

Co-Circulation of Influenza A(H1N1)pdm09 and Influenza A(H3N2) Viruses, World Health Organization (WHO) European Region, October 2018 to February 2019

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2019English

Susceptibility of Influenza A(h1n1)/Pdm2009, Seasonal A(H3N2) and B Viruses to Oseltamivir in Guangdong, China Between 2009 and 2014

Scientific Reports
Multidisciplinary
2017English

Synthetic Peptide Vaccine Confers Protection Against Murine Malaria

Journal of Experimental Medicine
MedicineAllergyImmunology
1987English

Potent Protection Against H5N1 and H7N9 Influenza via Childhood Hemagglutinin Imprinting

Science
MultidisciplinaryPhilosophy of ScienceHistory
2016English

Rules of Co-Occurring Mutations Characterize the Antigenic Evolution of Human Influenza a/H3n2, a/H1n1 and B Viruses

BMC Medical Genomics
Genetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy